Drug intelligence / Profile preview

EDX-110

Development stage
Unknown
Lead developer
Convatec
Modality
Small Molecules
Administration
Topical
01

Overview

EDX-110 is a topical nitric oxide-generating gel system developed by Edixomed Ltd for the treatment of various wound types, including superficial partial-thickness burns and skin graft donor sites. The system consists of two separate gel components—typically a nitrite-containing gel and an acidified buffer gel—which, when mixed upon application to the wound, react to release therapeutic levels of nitric oxide (NO) directly to the wound bed. Nitric oxide serves as a potent broad-spectrum antimicrobial agent and a critical signaling molecule in the wound healing cascade. It promotes vasodilation through the activation of soluble guanylate cyclase, stimulates fibroblast and keratinocyte proliferation, and modulates the inflammatory response to accelerate tissue regeneration and reduce the risk of infection in acute and chronic wounds.

Other names
Nitric oxide generating gelNOx generating gel dressingProNOx
02

Targets

sGC (Soluble Guanylyl Cyclase)

Beyond the preview

Go deeper on EDX-110.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EDX-110.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call